(Stroke. 1999;30:114-119.)
© 1999 American Heart Association, Inc.
Original Contributions |
From A.I. Virtanen Institute, University of Kuopio, Finland (J.K., S.P., J.Y.), Department of Neurology, Kuopio University Hospital, Kuopio, Finland (J.K.), and Department of Neurosurgery, Stanford University School of Medicine, Palo Alto, Calif (J.K., J.Y., P.H.C.).
Background and PurposePlasma glucose and spreading depression (SD) are both determinants of brain ischemia. The purpose of this study was to examine whether plasma glucose affects SD-induced gene expression in the cortex.
MethodsSD was induced by topical application of KCl.
Hyperglycemia and hypoglycemia were induced by
intraperitoneal injection of glucose and insulin,
respectively. The expression of c-fos,
cyclooxygenase-2 (COX-2), protein kinase C-
(PKC
), and heme oxygenase-1 (HO-1) was determined by in
situ hybridization.
ResultsSD alone induced expression of c-fos (by
340%), COX-2 (210%), HO-1 (470%), and PKC
(410%). Hypoglycemia
(2.4±0.9 mmol/L) alone did not induce gene expression, and
hyperglycemia (22.1±3.7 mmol/L) alone induced only
c-fos by 42%. When hypoglycemia was induced 30 minutes
before SD, c-fos induction was enhanced by 145%, but
the induction of HO-1 and PKC
was reduced to 43% and 64%,
respectively. When hyperglycemia was induced 30 minutes before SD,
c-fos induction was enhanced by 388% and COX-2
expression by 53%, whereas the induction of PKC
and HO-1 was
reduced to 54% and 51%, respectively. The frequency, amplitude, and
duration of direct current potentials were unaltered in hyperglycemic
SD animals, whereas in hypoglycemic animals the duration was increased
by 47%.
ConclusionsWhile SD induces expression of several genes, the availability of glucose regulates the extent of the gene induction. The effect of glucose is different on early-response genes (c-fos and COX-2) compared with late-response genes. Plasma glucose may contribute to neuronal damage partially by regulating gene expression.
Laboratory of Cerebrovascular Biology and Stroke, Department of Neurology, University of Minnesota, Minneapolis, Minnesota
This article has been cited by other articles:
![]() |
J. Alvarez-Sabin, C. A. Molina, M. Ribo, J. F. Arenillas, J. Montaner, R. Huertas, E. Santamarina, and M. Rubiera Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis: Risk Stratification in Relation to Time to Reperfusion Stroke, November 1, 2004; 35(11): 2493 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lindsberg and R. O. Roine Hyperglycemia in Acute Stroke Stroke, February 1, 2004; 35(2): 363 - 364. [Full Text] [PDF] |
||||
![]() |
J. Alvarez-Sabin, C. A. Molina, J. Montaner, J. F. Arenillas, R. Huertas, M. Ribo, A. Codina, and M. Quintana Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients Stroke, May 1, 2003; 34(5): 1235 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kent, V. M. Soukup, and R. H. Fabian Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse Stroke, October 1, 2001; 32(10): 2318 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koistinaho, S. Koponen, P. H. Chan, and C. Y. Hsu Expression of Cyclooxygenase-2 mRNA After Global Ischemia Is Regulated by AMPA Receptors and Glucocorticoids • Editorial Comment Stroke, September 1, 1999; 30(9): 1900 - 1906. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |